# Navitas Pharma jobs and careers

> 0 open roles at Navitas Pharma as of October 24, 2026. Source: https://www.thejobsmap.com/company/navitas-pharma

The company is repurposing cicletanine (CIC), a de-risked hypertension drug (launched in France but not the US; Navitas holds the US IND). Our work is supported by proprietary insights on mechanism of action, along with an aggressive intellectual-property strategy and a team with deep strength in organic chemistry and drug-product design. Current and pending patents include composition of matter for a new form of the drug, as well as use patents in cardiovascular, metabolic and other therapeutic domains. Earlier efforts involved a collaboration with Harvard that led to (1) asset sale to Gilead (including favorable return to investors) (2) publication of early results (pulmonary arterial hypertension) in the Archives of Internal Medicine: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/414546 A new understanding of the our drug's success in the above-mentioned case study has led to the generation of further intellectual property and opened new therapeutic opportunities.

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Employees | 1 to 10 |
| Website | https://femitas.com |

## Leadership

- Glenn Cornett, Chairman and Co-Founder

## Common questions

### Is Navitas Pharma hiring right now?

Navitas Pharma has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Navitas Pharma's careers site.

### Who leads Navitas Pharma?

Glenn Cornett, Chairman and Co-Founder, is at the top of Navitas Pharma's org chart.

### How do I apply for a job at Navitas Pharma?

Pick a role on Navitas Pharma's TheJobsMap page and select Apply. Every listing links to the original posting on Navitas Pharma's own careers site, so you apply directly with the employer.